Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States Of America et al v. Biogen IDEC, et al
Case Number:
1:14-cv-11908
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 03, 2016
Biogen Escapes 1 Of 4 FCA Suits Over Alleged Kickbacks
One of four whistleblower complaints accusing Biogen Inc. of violating the False Claims Act by paying millions of dollars in kickbacks to doctors as incentives and rewards for prescribing the company's multiple sclerosis drugs to Medicare patients was voluntarily dismissed from Massachusetts federal court Wednesday.
-
July 09, 2015
4 FCA Suits Allege Biogen Paid Kickbacks To Prescribers
A Massachusetts federal judge has unsealed four whistleblower complaints accusing Biogen Inc. of violating the False Claims Act by paying millions of dollars in kickbacks to doctors as incentives and rewards for prescribing the company's pricey multiple sclerosis drugs to Medicare patients.